查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球慢性血液透析导管市场 - 2023-2030
市场调查报告书
商品编码
1374768

全球慢性血液透析导管市场 - 2023-2030

Global Chronic Hemodialysis Catheter Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

多年来，全球慢性血液透析导管市场经历了显着的成长和转变，影响其动态的因素有很多。 HDC（血液透析导管）是肾臟替代疗法的重要组成部分。这些导管仅被视为安装更永久的血管通路（如动静脉瘘或移植物）之前的暂时解决方案。

政府投资和研究，特别是在发展中经济体，将继续推动先进技术的利用，并推动全球慢性血液透析导管市场的发展。各自的创新设备包括使用硅胶或聚氨酯等新型材料来实现更好的治疗。

市场动态：驱动因素

主要参与者越来越多收购血液透析导管

在高收入水准、投资和基础设施发展的推动下，已开发经济体的医疗保健产业不断改善。由于其积极的研究成果，一些国家对慢性血液透析导管的需求量很大。主要参与者之间的各种收购和产品发布将是推动市场成长的关键因素。

2023 年 6 月 8 日，国际公认的医疗保健技术製造商和分销商 Merit Medical Systems, Inc. 收购了 AngioDynamics, Inc. 的透析导管设备和活检道密封剂技术 BioSentry 组合，总现金估值1亿美元。

根据《国际临床实务期刊2022》通报，皖南医学院与弋矶山医院共同进行的研究结果显示，隧道式套囊导管（TCC）的平均存活时间超过两年。无论年龄、性别或原发疾病如何，我们发现TCC对于血管状况不佳或生存时间短的维持性血液透析（MHD）患者来说是一种有效的选择，或者作为等待内瘘生长的桥樑。

此外，越来越多地利用新技术或设备进行透析管理。人们意识的提高和创新设备开发研究的增加将是推动慢性血液透析导管市场成长的主要因素。

市场动态：限制

与导管相关的併发症

临床结果不佳的部分原因可能是长期埋设的血液透析导管造成的。血液透析导管的主要问题是感染、中心静脉狭窄和阻塞以及血栓和纤维蛋白鞘导致的功能不良。血栓形成或纤维蛋白鞘可能会导致血液透析不充分，因为它们会损害血流，特别是减少通过动脉腔的血流。

短期困难可能是由手术本身引起的，例如提供者缺乏经验、进入部位、放置技术、患者疾病的严重程度以及伴随条件。 HDC 的长期影响包括机械功能障碍、血栓形成、中心静脉狭窄和导管相关血流感染 (CRBSI)。

目录

第 1 章：方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义与概述

第 3 章：执行摘要

  • 按类型分類的片段
  • Tip Design 的片段
  • 涂层片段
  • 最终使用者的片段
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 主要参与者越来越多收购血液透析导管
      • 不断进步的技术进步与发展
    • 限制
      • 与导管相关的併发症
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 定价分析
  • SWOT分析
  • 专利分析
  • 俄乌战争影响分析
  • DMI 意见

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商策略倡议
  • 结论

第 7 章：按类型

  • 带套囊隧道导管
  • 无套囊隧道导管
  • 非隧道导管

第 8 章：透过尖端设计

  • 阶梯提示
  • 分离尖头
  • 对称尖头
  • 自定心尖端
  • Y 型尖端

第 9 章：透过涂层

  • 肝素涂层导管
  • 聚氨酯涂料
  • 抗生素涂层
  • 其他

第 10 章：最终用户

  • 医院
  • 专科诊所
  • 其他的

第 11 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 12 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 13 章：公司简介

  • Teleflex Incorporated
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Medtronic
  • BD
  • AngioDynamics
  • Medical Components, Inc.
  • Merit Medical Systems
  • Fresenius Medical Care AG & Co. KGaA
  • Haolang Technology (Foshan) Limited Co., Ltd.
  • SCW Medicath Ltd
  • Vygon

第 14 章：附录

简介目录
Product Code: MD7161

Overview

The global chronic hemodialysis catheter market has witnessed significant growth and transformations over the years, with various factors influencing its dynamics. HDCs (hemodialysis catheters) are a crucial component of kidney replacement therapy. These catheters are only seen as a temporary solution before installing more permanent vascular access, like arteriovenous fistulas or grafts.

Government investments and research, particularly in developing economies, will continue to drive utilization of advanced technologies and boost the global chronic hemodialysis catheter market. The respective innovative devices includes the use of novel materials such as silicone or polyurethane for better treatment.

Market Dynamics: Drivers

Growing acquisitions of hemodialysis catheters among key players

Developed economies have been witnessing rapid growth in betterment of their healthcare sectors, driven by high income levels, investments and infrastructure development. Several countries have experienced substantial demand for chronic hemodialysis catheter owing to its positive outcomes in research. Various acquisitions and product launches among key players will be a crucial factor driving the growth of the market.

On June 8, 2023, a portfolio of dialysis catheter devices and the Biopsy Tract Sealant Technology, BioSentry from AngioDynamics, Inc. have been acquired by Merit Medical Systems, Inc., an internationally recognized manufacturer and distributor of healthcare technology, for a total cash valuation of $100 million.

According to International Journal of Clinical Practices 2022, the results of the study conducted by Wannan Medical College associated with Yijishan Hospital show that the average Tunneled Cuffed Catheters (TCC) survive longer than two years. Regardless of age, sex, or primary condition, we discovered that TCC is an effective option for patients with Maintenance Hemodialysis (MHD) with poor vascular status or short survival time, or as a bridge while waiting for an internal fistula to grow.

Furthermore, the rising utilization of novel technologies or devices for the management of dialysis. Rising awareness among people and increasing research for innovative device development will be a major factor driving the growth of the chronic hemodialysis catheters market.

Market Dynamics: Restraints

Complications associated with the catheter

Poor clinical results may be caused in part by hemodialysis catheters that have been chronically tunneled. The main issues with hemodialysis catheters involve infection, central vein stenosis and blockage, and poor function brought on by thrombosis and fibrin sheath. Inadequate hemodialysis can result from thrombosis or fibrin sheath because they impair blood flow, especially by reducing inflow via the arterial lumen.

Short-term difficulties can be caused by the procedure itself, such as the inexperience of the provider, the site of access, the placement technique, the severity of the patient's disease, and concomitant conditions. The long-term effects of HDC include mechanical dysfunction, thrombosis, central venous stenosis, and catheter-related bloodstream infection (CRBSI).

Segment Analysis

The global chronic hemodialysis catheter market is segmented based on type, tip design, coating, end user and region.

Cuffed Tunneled Catheter segment holds approximately 41% of market share

Prior to the development or maturity of a long-term dialysis availability, such as an arteriovenous fistula (AVF) and arteriovenous grafty (AVG), tunneled catheters are utilized to provide vascular access. They are also utilized by patients who have used every available entry point for long-term access to dialysis. To reduce catheter disintegration, vascular harm, and catheter-related problems, tunneled catheters are composed of flexible materials like silicone or polyurethane-polycarbonate copolymer.

In general, polyurethane-polycarbonate copolymers are biocompatible. Tunneled cuffed catheters had been subsequently created, and the cuff's goal is to build a fibrous tissue that may act as a barrier preventing infection. Furthermore, by limiting displacement, the cuff and the related fibrous tissue may also offer a more stable access.

According to Indian Journal of Radiology and Imaging article 2023, tunneled lines are linked to greater long-term results, but the insertion procedure is more difficult and intrusive. In patients expected to need HD for longer than 2 to 3 weeks, cuffed TDCs are thus preferred over non-tunneled catheters, unless the situation is urgent and speedy access is required. The majority of qualified applicants for a TDC have a history of documented chronic kidney disease (CKD).

Geographical Penetration

North America accounted for around 33% of market share in 2022

Due to the rising need for chronic hemodialysis catheter in healthcare, manufacturers in North America have chances of increasing their operations. There are many producers and suppliers in North America and owing to the quick economic growth of the region, industrial production has expanded, driving the demand for chronic hemodialysis catheter.

Increasing expenditure on healthcare and rising research studies, advancement of technologies and different type of devices for management, and increase in pharmaceutical or medical device business establishment across the region are also contributing to the growth of chronic hemodialysis catheter market share of this region. The market in this area is growing as people become more aware of various novel innovative products such as tunneled catheters. The aforementioned elements further attest to North America's hegemonic position in the world.

North America continues to be a key player in the global chronic hemodialysis catheter market, with United States leading the way. Government initiatives promoting infrastructure development and investment, and a focus on rising advancements have fueled the demand for chronic hemodialysis catheter in the U.S. United States have been proactive in executing several initiatives or researches, stimulating chronic hemodialysis catheter demand.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global chronic hemodialysis catheter market. As countries grappled with lockdowns, supply chain disruptions and reduced economic activity, the pharmaceutical sector, with a significant consumer of various device designs, was significantly impacted. Several efforts all throughout the world were impacted by the pandemic's broad lockdowns and limitations that started in early 2020.

Major medical device industries came to a standstill and shifted their attention towards the management of COVID-19, leading to a slump in demand for chronic hemodialysis catheter. Now several research studies have been initiated and companies have again started trial for their products safety and efficacy. Overall, the impact of the pandemic on the global chronic hemodialysis catheter market is expected to be relatively moderate, with the market continuing to grow steadily due to the ongoing need and research for antimicrobial coated, self-cenetered catheter and other programs for management of renal kidney disease.

Key Developments

  • On August 21, 2023, the Arrow ErgoPack Comprehensive Kits with Hemodialysis plus Large Bore Catheters have been made available in the United States, according to Teleflex Incorporated, a top global manufacturer of medical technologies. The goal of this upgrade is to give clinicians more alternatives and streamline their insertion routine. With a selection of French diameters, lumens, and lengths, this extended kit configuration gives clinicians the option of using either Arrowg + ard Blue Hemodialysis and Large Bore lines.
  • On April 14, 2021, the U.S. Food and Drug Administration (FDA) granted 510(k) approval to BD (Becton, Dickinson and business), a preeminent worldwide medical technology business, for the Pristine a long-term Hemodialysis Catheter, a brand-new hemodialysis catheter with a distinctive symmetric Y-Tip side-hole free distal lumen design.

Competitive Landscape

The major global players in the market include: Teleflex Incorporated, Medtronic, BD, AngioDynamics, Medical Components, Inc., Merit Medical Systems, Fresenius Medical Care AG & Co. KGaA, Haolang Technology (Foshan) Limited Co., Ltd., SCW Medicath Ltd and Vygon.

Why Purchase the Report?

  • To visualize the global chronic hemodialysis catheter market segmentation based on type, tip design, coating, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of chronic hemodialysis catheter market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global chronic hemodialysis catheter market report would provide approximately 69 tables, 69 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Tip Design
  • 3.3. Snippet by Coating
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing acquisitions of hemodialysis catheters among key players
      • 4.1.1.2. Rising technological advancements and developments
    • 4.1.2. Restraints
      • 4.1.2.1. Complications associated with the catheter
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Pricing Analysis
  • 5.6. SWOT Analysis
  • 5.7. Patent Analysis
  • 5.8. Russia-Ukraine War Impact Analysis
  • 5.9. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Cuffed Tunneled Catheter*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Non-cuffed Tunneled Catheter
  • 7.4. Non-tunneled Catheter

8. By Tip Design

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 8.1.2. Market Attractiveness Index, By Tip Design
  • 8.2. Step-Tip*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Split-Tip
  • 8.4. Symmetrical-Tip
  • 8.5. Self-centering Tip
  • 8.6. Y-Tip

9. By Coating

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 9.1.2. Market Attractiveness Index, By Coating
  • 9.2. Heparin-coated Catheters *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Polyurethane Coating
  • 9.4. Antibiotic Coating
  • 9.5. Other

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Specialty Clinics
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tip Design
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Coating
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Teleflex Incorporated*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Medtronic
  • 13.3. BD
  • 13.4. AngioDynamics
  • 13.5. Medical Components, Inc.
  • 13.6. Merit Medical Systems
  • 13.7. Fresenius Medical Care AG & Co. KGaA
  • 13.8. Haolang Technology (Foshan) Limited Co., Ltd.
  • 13.9. SCW Medicath Ltd
  • 13.10. Vygon

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us